Skip to content

LifeStance Health Group LFST Amortization expense related to capitalized debt issuance costs

Amortization expense related to capitalized debt issuance costs at other companies

Acadia Healthcare logo
Acadia HealthcareACHC
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
Astrana Health logo
Astrana HealthASTH

Other financials

Income statement

See full
Revenue$403.5M+21.2%
Operating income$22.3M+1,289%
Net income$14.2M+1,909%
EPS (diluted)$0.04

Balance sheet

See full
Cash & equivalents$194.8M+45.0%
Total debt$476.8M-1.1%
Total equity$1.5B+1.4%
Total assets$2.1B+2.0%

Cash flow

See full
Operating cash flow$33.1M+1,171%
CapEx$10.8M+50.2%
Free cash flow$22.3M+318%

Valuation

See full
Market cap$3.6B-4.8%

Profitability

See full
Operating margin3%+2.4pp
Net margin1.6%+1.0pp
FCF margin9.5%+1.6pp

Returns & leverage

See full
Return on equity1.6%+1.0pp
Debt / equity0.3×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by LifeStance Health Group in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.

The official record: LifeStance Health Group’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LifeStance Health Group's amortization expense related to capitalized debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LifeStance Health Group's amortization expense related to capitalized debt issuance costs?
LifeStance Health Group (LFST) reported amortization expense related to capitalized debt issuance costs of $251K in Q1 2026.
How has LifeStance Health Group's amortization expense related to capitalized debt issuance costs changed year-over-year?
LifeStance Health Group's amortization expense related to capitalized debt issuance costs decreased by 0.0% year-over-year, from $251K to $251K.
What is the long-term trend for LifeStance Health Group's amortization expense related to capitalized debt issuance costs?
Over 4 years (2021 to 2025), LifeStance Health Group's amortization expense related to capitalized debt issuance costs has grown at a -13.2% compound annual growth rate (CAGR), from $1.8M to $1.02M.